SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Alpa Laboratories Ltd

BSE: 532878 NSE: ALPA ISIN: INE385I01010
  |   Sector:  Healthcare   |   Industry:  Pharmaceuticals & Drugs

Snapshot

Q.1 Which industry/sub-sector does Alpa Laboratories Ltd belong to?
Alpa Laboratories Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.
Q.2 Is Alpa Laboratories Ltd a good quality company?
Alpa Laboratories Ltd is a weak quality company, based on a inconsistent 10 year financial track record.
Q.3 Is Alpa Laboratories Ltd undervalued or overvalued?
Alpa Laboratories Ltd appears Somewhat overvalued, as its key valuation ratios are above with their past averages.
Q.4 Is Alpa Laboratories Ltd a good buy now?
Alpa Laboratories Ltd is a good buy now, based on strong price trend analysis suggesting prices may rise. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Alpa Laboratories Ltd?
Alpa Laboratories Ltd revenue growth is 3.4% for FY-2025 , which is below its 5 year CAGR of 5.5% , indicating slower growth.
Q.2 Gross Profit margin of Alpa Laboratories Ltd?
Alpa Laboratories Ltd Gross profit margin which is the profit after deduction of direct costs, is 24.9% for FY-2025 , which is above its 5 year median of 18.9% , indicating increasing margins.
Q.3 Operating Profit Margin of Alpa Laboratories Ltd?
Alpa Laboratories Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 4.5% for FY-2025 , which is below its 5 year median of 8.7% indicating decreasing margins.
Q.4 Net Profit Margin of Alpa Laboratories Ltd?
Alpa Laboratories Ltd Net Profit Margin is 17.5% for FY-2025 , is above with its 5 year median of 13.58%, indicating increasing margins.
Current Level Historic Median
Gross Profit Margin 24.9 18.9
Operating Profit Margin 4.5 8.7
Net Profit Margin 17.5 13.58
Q.5 Return on Asset of Alpa Laboratories Ltd?
Alpa Laboratories Ltd Return on Asset is 9.25%, which is above its 5 year historical median of 8.96%, indicating improved asset utilization efficiency.
Q.6 Return on Equity (ROE) of Alpa Laboratories Ltd?
Alpa Laboratories Ltd Return on equity is 11.45% for FY-2025 , which is above its historical median of 10.93%, indicating the business is making better use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Alpa Laboratories Ltd?
Alpa Laboratories Ltd Return on capital employed is 14.96% for FY-2025 , which is above its estimated weighted average cost of capital(WACC) 14%, indicating value creation.
Q.8 Cash conversion cycle of Alpa Laboratories Ltd?
Alpa Laboratories Ltd Cash conversion cycle is 140 days, above its historical median of 140 days, indicating deteriorated working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 0.53 0.59
ROE 11.45 10.93
ROCE 14.96 13.38
Cash Conversion Cycle 140 days 140 days
Q.9 Debt to Equity ratio of Alpa Laboratories Ltd?
Alpa Laboratories Ltd Debt-to-Equity ratio is 0.00 , which is lower with the industry average of 0.15 , indicating lower debt levels in the industry.
Q.10 Debt to cash flow from operations of Alpa Laboratories Ltd?
Alpa Laboratories Ltd Debt to cash flow from operations is 0 , which is at a healthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Alpa Laboratories Ltd?
Promoters hold 57.29% of the Alpa Laboratories Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Alpa Laboratories Ltd vs industry peers?
Alpa Laboratories Ltd revenue CAGR is 5.52% , compared to the industry median CAGR of 5.54% , indicating slower growth and losing its market share.
Profit Metrics
Current Level Industry Median
Revenue 112.5 137.1
Gross Profit 27.9 15.1
Operating Profit 5 16
Net Profit 20 5.6
Operating Efficiency
Current Level Industry Median
Asset Turnover 0.53 0.8
ROE 11.45 8.91
ROCE 14.96 11.59
Cash Conversion Cycle (days) 139.51 76

Valuation & price assessment

Q.1 Stock return of Alpa Laboratories Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 7% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price 7% 6.8% 5.1% -36.5%
Q.3 Valuation ratios of Alpa Laboratories Ltd vs historical?
The current P/E is higher that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings 12.31 10.30 40.28
Price to Book 0.74 0.50 2.77
Price to Sales 1.28 0.70 2.65
EV to EBITDA 7.99 6.56 15.67

Check more companies

1. Ajanta Pharma
2. JB Chem & Pharma
3. Emcure Pharma
4. Gland Pharma
5. Wockhardt
6. Pfizer
7. Astrazeneca Pharma I
8. Sai Life Sciences
9. Natco Pharma
10. Eris Lifesciences
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×